drugset / Trial / NCT03622450
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
RandomizedParallel-groupTriple-blindTreatment
Summary
The study has been conducted to measure the clinical outcome of early intervention with colistin inhalation in patients with ventilator associated pneumonia suspected to have multidrug resistant gram -ve bacteria
Timeline
- Start
- 2016-01-02
- Primary completion
- 2018-01-06
- Completion
- 2018-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amikacin | Small molecule | — | Intravenous |
| Comparator | Ciprofloxacin | Small molecule | 500 mg | Intravenous |
| Subject | Colistin | Other / unclassified | 2e+06 unknown | Inhaled |
| Comparator | Gentamicin | Small molecule | — | Intravenous |
| Comparator | IMIPENEM ANHYDROUS | Small molecule | 1 g | Intravenous |
| Comparator | Levofloxacin | Small molecule | 750 mg | Intravenous |
| Comparator | Meropenem | Small molecule | 1 g | Intravenous |
Indications
No indication recorded.